- Home
- SGMO vs OPRX Comparison
SGMO vs OPRX Comparison
Compare SGMO & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGMO | OPRX |
|---|---|---|
| Founded | 1995 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2M | 115.4M |
| IPO Year | 2000 | 2008 |
Fundamental Metrics
Financial Performance| Metric | SGMO | OPRX |
|---|---|---|
| Price | $0.26 | $6.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $7.00 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 7.4M | 498.8K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.20 | ★ 124.55 |
| EPS | N/A | ★ 0.27 |
| Revenue | $36,567,000.00 | ★ $109,429,000.00 |
| Revenue This Year | $24.46 | $3.88 |
| Revenue Next Year | $193.67 | $8.49 |
| P/E Ratio | ★ N/A | $22.70 |
| Revenue Growth | ★ 88.60 | 18.78 |
| 52 Week Low | $0.21 | $5.54 |
| 52 Week High | $0.84 | $22.25 |
Technical Indicators
Market Signals| Indicator | SGMO | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 35.23 | 38.19 |
| Support Level | $0.21 | $5.89 |
| Resistance Level | $0.55 | $7.47 |
| Average True Range (ATR) | 0.04 | 0.51 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 25.91 | 9.18 |
Price Performance
Historical ComparisonAbout SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.